MEB braces itself for ‘hard Brexit’
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
Strengthening cooperation with other European medicines authorities” is a priority for the Dutch medicines agency, the MEB, as it prepares for “the worst-case scenario” of a UK ‘hard Brexit’ from the European Union (EU) in March 2019, according to the agency’s president Hugo Hurts.